Clinical Trial

Venus-Vitae Pivotal Study Smart-Align Study

Not Yet Recruiting
View on ClinicalTrials.gov →
Record status
This record was last updated August 18, 2023 (before its estimated December 31, 2024 completion). Its status may not reflect the trial's current state.
Summary
The purpose is to evaluate the safety, effectiveness and performance of Venus-Vitae Transcatheter Heart Valve System in patients with severe aortic stenosis.
Protocol Amendment History 1 amendment
This ClinicalTrials.gov record has been amended once since 2023-08-10.
Trial Details
NCT Number NCT05991271
Lead Sponsor Venus MedTech (HangZhou) Inc.
Conditions Aortic Valve Stenosis
Enrollment 150 participants
Start Date 2023-10-31
Primary Completion 2024-12-31 (estimated)
Study Completion 2029-06-30 (estimated)
Updated on ClinicalTrials.gov 2023-08-18